CN112384634A - 骨质疏松生物标志物及其用途 - Google Patents
骨质疏松生物标志物及其用途 Download PDFInfo
- Publication number
- CN112384634A CN112384634A CN201880092711.2A CN201880092711A CN112384634A CN 112384634 A CN112384634 A CN 112384634A CN 201880092711 A CN201880092711 A CN 201880092711A CN 112384634 A CN112384634 A CN 112384634A
- Authority
- CN
- China
- Prior art keywords
- analog
- ruminococcus
- bacteroides
- osteoporosis
- biomarker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000001132 Osteoporosis Diseases 0.000 title claims abstract description 188
- 239000000090 biomarker Substances 0.000 title claims abstract description 140
- 241000192031 Ruminococcus Species 0.000 claims abstract description 62
- 241000606123 Bacteroides thetaiotaomicron Species 0.000 claims abstract description 52
- 241000047484 Bacteroides intestinalis Species 0.000 claims abstract description 21
- 241000606219 Bacteroides uniformis Species 0.000 claims abstract description 16
- 241001105998 Bacteroides dorei Species 0.000 claims abstract description 15
- 241000134861 Ruminococcus sp. Species 0.000 claims abstract description 14
- 241001624700 Dialister invisus Species 0.000 claims abstract description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 101
- 201000010099 disease Diseases 0.000 claims description 78
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 78
- 238000012163 sequencing technique Methods 0.000 claims description 76
- 238000000034 method Methods 0.000 claims description 51
- 150000007523 nucleic acids Chemical class 0.000 claims description 40
- 230000000968 intestinal effect Effects 0.000 claims description 32
- 108020004707 nucleic acids Proteins 0.000 claims description 32
- 102000039446 nucleic acids Human genes 0.000 claims description 32
- 244000005700 microbiome Species 0.000 claims description 25
- 238000007637 random forest analysis Methods 0.000 claims description 24
- 241000702462 Akkermansia muciniphila Species 0.000 claims description 16
- 241000204306 Parabacteroides merdae Species 0.000 claims description 16
- 239000003814 drug Substances 0.000 claims description 15
- 241000606125 Bacteroides Species 0.000 claims description 12
- 238000013179 statistical model Methods 0.000 claims description 12
- 238000012216 screening Methods 0.000 claims description 11
- 238000012360 testing method Methods 0.000 claims description 10
- 238000003745 diagnosis Methods 0.000 claims description 9
- 241001464870 [Ruminococcus] torques Species 0.000 claims description 8
- 244000005709 gut microbiome Species 0.000 claims description 8
- 230000001009 osteoporotic effect Effects 0.000 claims description 8
- 239000003153 chemical reaction reagent Substances 0.000 claims description 7
- 241000828235 Ruminococcus sp. 5_1_39BFAA Species 0.000 claims description 5
- 238000004590 computer program Methods 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- 238000007671 third-generation sequencing Methods 0.000 claims description 5
- 241000590020 Achromobacter Species 0.000 claims description 3
- 241000778935 Akkermansia muciniphila ATCC BAA-835 Species 0.000 claims description 3
- 241001496720 Bacteroides intestinalis DSM 17393 Species 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 241000191940 Staphylococcus Species 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000004393 prognosis Methods 0.000 claims 1
- 241000894007 species Species 0.000 description 36
- 238000012549 training Methods 0.000 description 23
- 239000003550 marker Substances 0.000 description 19
- 238000010200 validation analysis Methods 0.000 description 15
- 108020004414 DNA Proteins 0.000 description 13
- 241000282414 Homo sapiens Species 0.000 description 12
- 238000001514 detection method Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 210000000988 bone and bone Anatomy 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 208000010392 Bone Fractures Diseases 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 210000001035 gastrointestinal tract Anatomy 0.000 description 7
- 206010017076 Fracture Diseases 0.000 description 6
- 230000037182 bone density Effects 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 238000004364 calculation method Methods 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 238000012165 high-throughput sequencing Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 5
- 238000002790 cross-validation Methods 0.000 description 4
- 239000002207 metabolite Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000007619 statistical method Methods 0.000 description 4
- 238000000528 statistical test Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000012795 verification Methods 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 241000702460 Akkermansia Species 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000013399 early diagnosis Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000007400 DNA extraction Methods 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000012350 deep sequencing Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 229940000406 drug candidate Drugs 0.000 description 2
- 239000003596 drug target Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 108091008053 gene clusters Proteins 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000012502 risk assessment Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 101150096372 1.3 gene Proteins 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 241001391944 Commicarpus scandens Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 241001535083 Dialister Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 238000000585 Mann–Whitney U test Methods 0.000 description 1
- 241000863420 Myxococcus Species 0.000 description 1
- 208000001164 Osteoporotic Fractures Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000962939 Parabacteroides merdae ATCC 43184 Species 0.000 description 1
- 208000002500 Primary Ovarian Insufficiency Diseases 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010001584 alcohol abuse Diseases 0.000 description 1
- 208000025746 alcohol use disease Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000012098 association analyses Methods 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000007481 next generation sequencing Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 206010036601 premature menopause Diseases 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
Abstract
本发明涉及骨质疏松生物标志物及其用途。所述生物标志物包括多形拟杆菌(Bacteroides thetaiotaomicron)，单形拟杆菌(Bacteroides uniformis)，Bacteroides intestinalis，Bacteroides dorei，瘤胃球菌(Ruminococcus sp.)，嗜粘蛋白‑艾克曼菌Akkermansia muciniphila，Parabacteroides merdae，扭链瘤胃球菌Ruminococcus torques，Dialister invisus及它们的类似物。
Description
PCT国内申请，说明书已公开。
Claims (34)
- PCT国内申请，权利要求书已公开。
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2018/084276 WO2019204985A1 (zh) | 2018-04-24 | 2018-04-24 | 骨质疏松生物标志物及其用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112384634A true CN112384634A (zh) | 2021-02-19 |
| CN112384634B CN112384634B (zh) | 2024-04-16 |
Family
ID=68294361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201880092711.2A Active CN112384634B (zh) | 2018-04-24 | 2018-04-24 | 骨质疏松生物标志物及其用途 |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN112384634B (zh) |
| WO (1) | WO2019204985A1 (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020030709A1 (en) | 2018-08-09 | 2020-02-13 | Sony Corporation | Methods, communications device and infrastructure equipment |
| CN112957376A (zh) * | 2019-12-14 | 2021-06-15 | 山东大学 | 一种调节高原人群血糖的微生物组合物及其应用 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1515254A (zh) * | 1996-02-28 | 2004-07-28 | 骨质疏松症的联合疗法 | |
| CN102154450A (zh) * | 2010-12-23 | 2011-08-17 | 深圳华大基因科技有限公司 | 一种检测肠炎致病菌的方法 |
| WO2015170979A1 (en) * | 2014-05-06 | 2015-11-12 | Is-Diagnostics Ltd. | Microbial population analysis |
| CN107075446A (zh) * | 2014-09-30 | 2017-08-18 | 深圳华大基因科技有限公司 | 用于肥胖症相关疾病的生物标记物 |
-
2018
- 2018-04-24 CN CN201880092711.2A patent/CN112384634B/zh active Active
- 2018-04-24 WO PCT/CN2018/084276 patent/WO2019204985A1/zh active Application Filing
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1515254A (zh) * | 1996-02-28 | 2004-07-28 | 骨质疏松症的联合疗法 | |
| CN102154450A (zh) * | 2010-12-23 | 2011-08-17 | 深圳华大基因科技有限公司 | 一种检测肠炎致病菌的方法 |
| WO2015170979A1 (en) * | 2014-05-06 | 2015-11-12 | Is-Diagnostics Ltd. | Microbial population analysis |
| CN107075446A (zh) * | 2014-09-30 | 2017-08-18 | 深圳华大基因科技有限公司 | 用于肥胖症相关疾病的生物标记物 |
Non-Patent Citations (1)
| Title |
|---|
| 董万涛;黄凯;宋敏;侯红燕;宋志靖;周灵通;刘小钰;蒋林博;: "肠道微生态失衡为骨质疏松症发病的易感因素", 中国骨质疏松杂志, no. 03, pages 119 - 123 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112384634B (zh) | 2024-04-16 |
| WO2019204985A1 (zh) | 2019-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111430027B (zh) | 基于肠道微生物的双相情感障碍生物标志物及其筛选应用 | |
| CN112119167B (zh) | 抑郁症生物标志物及其用途 | |
| CN105368944B (zh) | 可检测疾病的生物标志物及其用途 | |
| Shi et al. | Alterations in the intestinal microbiota of patients with severe and active Graves’ orbitopathy: a cross-sectional study | |
| CN110904213B (zh) | 一种基于肠道菌群的溃疡性结肠炎生物标志物及其应用 | |
| CN104603283A (zh) | 确定异常状态相关生物标志物的方法及系统 | |
| CN110241205A (zh) | 一种基于肠道菌群的精神分裂症生物标志物组合及其应用与筛选 | |
| CN111020020A (zh) | 一种精神分裂症的生物标志物组合、其应用及metaphlan2筛选方法 | |
| CN104769132A (zh) | 肝脏相关的炎性疾病的基因标记 | |
| CN111505288A (zh) | 一种新的抑郁症生物标志物及其应用 | |
| CN110838365A (zh) | 肠易激综合症相关菌群标志物及其试剂盒 | |
| CN112748191A (zh) | 诊断急性疾病的小分子代谢物生物标志物及其筛选方法和应用 | |
| CN112384634B (zh) | 骨质疏松生物标志物及其用途 | |
| CN110396538B (zh) | 偏头痛生物标志物及其用途 | |
| CN113913490A (zh) | 非酒精性脂肪肝标志微生物及其应用 | |
| CN114317671A (zh) | 可作为1型糖尿病生物标志物的肠道细菌和粪便代谢物及其应用 | |
| CN111020021A (zh) | 一种基于肠道菌群的小规模精神分裂症生物标志物组合、其应用及mOTU筛选方法 | |
| CN112011605B (zh) | 微生物菌群在疾病诊断中的应用 | |
| CN109689890A (zh) | 用于子宫腺肌症检测的生物标志物组合及其应用 | |
| CN110396537B (zh) | 哮喘生物标志物及其用途 | |
| CN109266733B (zh) | 自闭症肠道菌群毒力因子基因及其应用 | |
| CN112063709A (zh) | 一种以微生物作为诊断标志物的重症肌无力的诊断试剂盒及应用 | |
| CN112877417A (zh) | 多囊卵巢综合征肠道菌群生物标志物筛选及其应用 | |
| CN113166815B (zh) | 肠道宏基因组在筛选pd-1抗体阻断剂疗效方面的用途 | |
| US20240290431A1 (en) | Biomarker and diagnosis system for colorectal cancer detection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |